InflaRx

Performance

About InflaRx

InflaRx is a biopharmaceutical company focused on applying its proprietary anti-C5a and C5aR inhibitors to the treatment of life-threatening or debilitating inflammatory diseases with high unmet medical need. The company emphasizes innovative science for the discovery and development of transformative treatments for patients, with operations in multiple locations including Jena, Martinsried (Germany) and Ann Arbor (USA). Its portfolio centers on the complement system, aiming to develop highly potent and specific inhibitors of C5a and its receptor C5aR to address inflammatory conditions. InflaRx also communicates its ongoing clinical development efforts and regulatory considerations surrounding its therapies.